Immuneering Corp

General ticker "IMRX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $60.0M

Immuneering Corp does not follow the US Stock Market performance with the rate: -22.3%.

Estimated limits based on current volatility of 8.9%: low 1.73$, high 2.06$

Factors to consider:

  • Current price 47.5% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [4.25$, 10.30$]
  • 2024-12-30 to 2025-12-30 estimated range: [4.12$, 9.93$]

Financial Metrics affecting the IMRX estimates:

  • Negative: Non-GAAP EPS, $ of -1.89 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -18.73 <= 2.35
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term IMRX quotes

Long-term IMRX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $2.08MM $0.32MM $0.00MM
Operating Expenses $35.97MM $52.06MM $58.41MM
Operating Income $-33.89MM $-51.74MM $-58.41MM
Non-Operating Income $0.04MM $1.23MM $4.94MM
Interest Expense $0.00MM $1.01MM $0.00MM
R&D Expense $26.54MM $36.27MM $41.40MM
Income(Loss) $-33.84MM $-50.51MM $-53.47MM
Taxes $-0.31MM $0.00MM $0.00MM
Profit(Loss) $-33.54MM $-50.51MM $-53.47MM
Stockholders Equity $155.98MM $109.85MM $90.58MM
Inventory $0.00MM $0.00MM $0.00MM
Assets $166.70MM $122.37MM $102.58MM
Operating Cash Flow $-30.85MM $-44.10MM $-48.97MM
Capital expenditure $0.06MM $0.74MM $0.34MM
Investing Cash Flow $-75.62MM $41.83MM $7.30MM
Financing Cash Flow $144.26MM $0.02MM $28.44MM
Earnings Per Share* $-1.27 $-1.87 $-1.88

* EPS are Split Adjusted, recent splits may be reflected with a delay.